Acciones Sigilon Therapeutics, Inc.
Acciones
SGTX
US82657L2060
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 60 | 14/08/18 | |
Director of Finance/CFO | 58 | 01/11/19 | |
Philip Johnson
PSD | President | 59 | 11/08/23 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 60 | 14/08/18 | |
Philip Johnson
PSD | President | 59 | 11/08/23 |
Gordon Brooks
BRD | Director/Board Member | - | 11/08/23 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+4,09 % | 43,84 mil M | |
+46,79 % | 41,25 mil M | |
+9,45 % | 41,68 mil M | |
-10,92 % | 27,04 mil M | |
+9,32 % | 25,53 mil M | |
-24,87 % | 18,18 mil M | |
+29,70 % | 12,29 mil M | |
+1,28 % | 12,29 mil M | |
+7,78 % | 11,15 mil M |